Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials. (Q41035635)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 December 2015

Language	Label	Description	Also known as
English	Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials.	scientific article published on 19 December 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

Ganessan Kichenadasse

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Michael J. Sorich

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Richard J Woodman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Andrew Rowland

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Arduino A Mangoni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

0 references

publication date

6 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2293-2299

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Clinical biomarkers of response in advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Fetal uninephrectomy in male sheep alters the systemic and renal responses to angiotensin II infusion and AT1R blockade.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

T-type calcium channels blockers as new tools in cancer therapies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Methods for dealing with time-dependent confounding

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29972

21 January 2018

Identifiers

10.1002/IJC.29972

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26685869%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41035635&oldid=2093369395"